Anticardiolipin and anti-beta-2 glycoprotein I antibodies in patients with moderate or severe COVID-19-Reference-Cited by-同舟云学术

Anticardiolipin and anti-beta-2 glycoprotein I antibodies in patients with moderate or severe COVID-19

Published:2023-02 Issue:2 Volume:365 Page:215-217
ISSN:0002-9629
Container-title:The American Journal of the Medical Sciences
language:en
Short-container-title:The American Journal of the Medical Sciences

Author:

Garcia-Arellano Gisela,Camacho-Ortiz Adrian,Moreno-Arquieta Ilse Andrea,Cardenas-de la Garza Jesus Alberto,Rubio-Torres Diana Carolina,Garza-Gonzalez Elvira,Bocanegra-Ibarias Paola,Galarza-Delgado Dionicio Angel

Publisher

Elsevier BV

Subject

General Medicine

Reference9 articles.

1. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19;Zhang;N Engl J Med,2020

2. Presence of antiphospholipid antibodies in COVID-19: a case series study;Amezcua-Guerra;Ann Rheum Dis,2021

3. COVID-19 and aPL Antibodies: Frequently Asked Questions. (https://www.hematology.org/covid-19/covid-19-and-apl-ab). Accessed November 11, 2021.

4. Autoantibodies in COVID-19: frequency and function;wei;Autoimmun Rev,2021

5. Assessment of Lupus Anticoagulant Positivity in Patients With Coronavirus Disease 2019 (COVID-19);Reyes Gil;JAMA Netw Open,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IgA Anti-β2-Glycoprotein I Antibodies as Markers of Thrombosis and Severity in COVID-19 Patients;Viruses;2024-07-03

2. IgA is the predominant isotype of anti-β2 glycoprotein I in patients with COVID-19;Laboratory Medicine;2023-12-20

3. A case of development of membranous nephropathy against the background of atypical hemolytic-uremic syndrome activated as a result of acute respiratory viral infection;South Russian Journal of Therapeutic Practice;2023-12-13

4. Anticardiolipin and anti‐beta 2‐glycoprotein I antibodies in patients with unexplained articular manifestations;Journal of Clinical Laboratory Analysis;2022-12-13